NCT06094101: Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 30 planned
- Started
- 19 Sep 2023
- Primary completion
- Jun 2027
- Arms
- Peptide vaccination
- Results
- None posted
- 19 Sep 2023: Trial started
- 23 Oct 2023: Trial registered